Pharmaceutical Technology

OCTOBER 25, 2022

Breaches of HIPAA in the US can result in fines of up to $50,000. One solution that increasing numbers of pharmaceutical companies, healthcare providers, and clinical research organisations are turning to is Cassie by Syrenis, which is a Consent Management Platform (CMP). Grouping and matching for medical data.

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies Medical Records 52

Pharma Marketing Network

JUNE 8, 2020

Now most pharmaceutical companies that are global in nature will already encounter this from a European compliance standpoint with the GDPR regulation that is more geared toward the US European union. So, this isn’t really something that would technically be super new to pharmaceutical companies that are global.

HIPAA 40

HIPAA Pharmaceutical Companies Pharmaceutical Companies Communication 40

FDA Law Blog: Biosimilars

MAY 26, 2025

2018), the district court ruled that Congress had exceed its constitutional bounds and had no authority to pass this law under the Necessary and Proper Clause or the Commerce Clause. 18-1156, 2018 U.S. Specifically, in United States v. Nagarwala , 350 F. See United States v. Nagarwala , No. LEXIS 37299 (6th Cir.

Labelling 59

Labelling HIPAA Documentation Immunity 59